The limited scope of antiviral drugs and increasing problem of antiviral drug resistance represent a global health threat. Glycopeptide antibiotics and their lipophilic derivatives have emerged as relevant inhibitors of diverse viruses. Herein, we describe a new strategy for the synthesis of dual hydrophobic and lipophobic derivatives of glycopeptides to produce selective antiviral agents without membrane-disrupting activity. Perfluorobutyl and perfluorooctyl moieties were attached through linkers of different length to azido derivatives of vancomycin aglycone and teicoplanin pseudoaglycone, and the new derivatives were evaluated against a diverse panel of viruses. The teicoplanin derivatives displayed strong anti-influenza virus activity at nontoxic concentrations. Some of the perfluoroalkylated glycopeptides were also active against a few other viruses such as herpes simplex virus or coronavirus. These data encourage further exploration of glycopeptide analogues for broad antiviral application.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540527PMC
http://dx.doi.org/10.1002/cmdc.202000260DOI Listing

Publication Analysis

Top Keywords

derivatives
6
synthesis antiviral
4
antiviral perfluoroalkyl
4
perfluoroalkyl derivatives
4
derivatives teicoplanin
4
teicoplanin vancomycin
4
vancomycin limited
4
limited scope
4
antiviral
4
scope antiviral
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!